Advertisement
Advertisement

INDV

INDV logo

Indivior Pharmaceuticals, Inc. Common Stock

36.76
USD
Sponsored
-1.07
-2.83%
May 15, 15:59 UTC -4
Closed
exchange

After-Market

36.35

-0.41
-1.10%

Indivior Pharmaceuticals, Inc. Common Stock Profile

About

Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.

Info & Links

CEO

Joseph Ciaffoni

Headquarters

10710 Midlothian Turnpike Suite 125
North Chesterfield, VA 23235, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.indivior.com

Auditor

PricewaterhouseCoopers LLP

Share holders

139

Employees

838

Indivior Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.30B

Enterprise Value

4.42B

Enterprise Value/EBITDA(ttm)

15.68

Price to Earnings Ratio(ttm)

13.13

Price to Sales(ttm)

3.18

Price to Book(mrq)

--

Price to Cash(ytd)

11.88

Profitability

Gross Margin(ttm)

80.30%

Operating Margin(ttm)

25.40%

Profit Margin(ttm)

16.46%

Return on Equity(ttm)

-148.76%

Return on Invested Capital(ttm)

313.01%

Return on Assets(ttm)

23.15%

Income Statement

Revenue(ttm)

1.24B

Revenue Per Share(ttm)

9.91

Gross Profit(ttm)

994.00M

EBITDA(ttm)3

282.00M

Net Income Available to Common(ttm)

210.00M

Diluted EPS(ttm)

1.64

Share Statistics

Beta (5Y Monthly)

0.88

52-Week Change

224.16%

S&P 500 52-Week Change

24.23%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

125.07M

Dividend Yield

0.00%

Float4

121.02M

% Held by Insiders

0.74%

% Held by Institutions

60.33%

Balance Sheet

Total Cash(mrq)

195.00M

Total Cash Per Share(mrq)

1.56

Total Debt(mrq)

319.00M

Total Debt/Equity(mrq)

-325.51%

Current Ratio(mrq)

0.71%

Quick Ratio(mrq)

0.55%

Book Value Per Share(mrq)

-0.78

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.21

Free Cash Flow(ytd)

-93.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement